These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8071118)

  • 1. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.
    Saikawa Y; Kubota T; Furukawa T; Suto A; Watanabe M; Kumai K; Ishibiki K; Kitajima M
    Jpn J Cancer Res; 1994 Jul; 85(7):762-5. PubMed ID: 8071118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers.
    Abe S; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M
    Anticancer Res; 1999; 19(5C):4581-6. PubMed ID: 10650814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.
    Kubota T; Egawa T; Otani Y; Furukawa T; Saikawa Y; Yoshida M; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2003; 23(1B):583-7. PubMed ID: 12680150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy.
    Nakamura R; Saikawa Y; Kubota T; Kumagai A; Kiyota T; Ohashi M; Yoshida M; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2006; 26(2B):1433-7. PubMed ID: 16619555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.
    Iwahashi M; Nakamori M; Nakamura M; Noguchi K; Ueda K; Nakatani Y; Ojima T; Ishida K; Naka T; Yamaue H
    Anticancer Res; 2005; 25(5):3453-9. PubMed ID: 16101163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.
    Yamaue H; Tanimura H; Noguchi K; Hotta T; Tani M; Tsunoda T; Iwahashi M; Tamai M; Iwakura S
    Br J Cancer; 1992 Nov; 66(5):794-9. PubMed ID: 1419622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay.
    Noguchi K; Iwahashi M; Tani M; Nakamura M; Nakamori M; Nakatani Y; Ueda K; Ishida K; Naka T; Ojima T; Hotta T; Mizobata S; Yamaue H
    Anticancer Res; 2005; 25(2A):931-7. PubMed ID: 15868930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer.
    Fujita K; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M
    Anticancer Res; 1998; 18(3B):1973-8. PubMed ID: 9677452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of chemosensitivity test for advanced colorectal cancer.
    Kabeshima Y; Kubota T; Watanabe M; Hasegawa H; Furukawa T; Kitajima M
    Anticancer Res; 2002; 22(5):3033-7. PubMed ID: 12530038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
    Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution's experience.
    Wu B; Zhu JS; Zhang Y; Shen WM; Zhang Q
    World J Gastroenterol; 2008 May; 14(19):3064-8. PubMed ID: 18494060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of chemosensitivity testing using the MTT assay.
    Furukawa T; Kubota T; Suto A; Takahara T; Yamaguchi H; Takeuchi T; Kase S; Kodaira S; Ishibiki K; Kitajima M
    J Surg Oncol; 1991 Nov; 48(3):188-93. PubMed ID: 1943116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
    Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray.
    Suganuma K; Kubota T; Saikawa Y; Abe S; Otani Y; Furukawa T; Kumai K; Hasegawa H; Watanabe M; Kitajima M; Nakayama H; Okabe H
    Cancer Sci; 2003 Apr; 94(4):355-9. PubMed ID: 12824904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in inoperable, locally advanced, and inflammatory breast carcinoma: a pilot study of MTT assay in vitro and outcome analysis of 10 patients.
    Xu JM; Song ST; Tang ZM; Jiang ZF; Liu XQ; Zhang J; Liu XW; Paradiso A
    Am J Clin Oncol; 2001 Jun; 24(3):259-63. PubMed ID: 11404497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay.
    Yamaue H; Tanimura H; Nakamori M; Noguchi K; Iwahashi M; Tani M; Hotta T; Murakami K; Ishimoto K
    Dis Colon Rectum; 1996 Apr; 39(4):416-22. PubMed ID: 8878502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent antitumor spectrum of UCN-01 (7-hydroxystaurosporine) against gastric and colorectal cancers as detected by MTT assay.
    Abe S; Kubota T; Saikawa Y; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2002; 22(6B):3605-10. PubMed ID: 12552963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay.
    Maeda S; Saikawa Y; Kubota T; Aoki M; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2003; 23(4):3147-50. PubMed ID: 12926047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.